네오헤스페리딘 디하이드로칼콘을 포함하는 동맥경화증,고지혈증, 간 질환, 고혈당증의 예방 및 치료용 조성물
    22.
    发明公开
    네오헤스페리딘 디하이드로칼콘을 포함하는 동맥경화증,고지혈증, 간 질환, 고혈당증의 예방 및 치료용 조성물 失效
    含有NEOHESPERIDIN DIHYDROCHALCONE的组合物可用于预防和治疗ARTERIOSCLEROSIS,HYPERLIPEMIA,肝脏疾病和GLYCOSEMIA

    公开(公告)号:KR1020010007624A

    公开(公告)日:2001-01-26

    申请号:KR1020000058788

    申请日:2000-10-06

    Abstract: PURPOSE: A composition containing neohesperidin dihydrochalcone generally used as a sweetener is provided for preventing and treating arteriosclerosis, hyperlipemia, liver diseases, and glycosemia. CONSTITUTION: Neohesperidin dihydrochalcone(C28H36O15, M.W. 612.60) is obtained by extracting from the rind or outer layer of grapefruit or by chemically changing Naringin, and it is sweeter 1,500 to 2,000 times than sugar per unit weight. Therefore it has been usually used as a sweetener not a medicinal material. The composition containing an effective amount of neohesperidin dihydrochalcone, that is, 0.1 to 500 mg/kg, preferably 1 to 100 mg/kg a day, is orally or topically administrated into a patient and the amount of administration may be variable by patient's age, weight, sex, health, diet, severity of disease, and so on. The composition containing neohesperidin dihydrochalcone may be added into foods and drinks in an amount of 0.01 to 20 wt.%, preferably 0.1 to 5 wt.% of diosmin.

    Abstract translation: 目的:提供通常用作甜味剂的含有新皮质激素二氢查耳酮的组合物,用于预防和治疗动脉硬化,高脂血症,肝脏疾病和糖血症。 构成:通过从葡萄柚的外层或外层提取或通过化学改变柚皮苷获得新的皮肤色素二氢查耳酮(C28H36O15,M.W.612.60),并且比单位重量的糖更甜1,500-2000倍。 因此,它通常用作不是药用材料的甜味剂。 将包含有效量的新橙皮苷二氢查耳酮,即0.1至500mg / kg,优选1至100mg / kg每天的组合物口服或局部施用于患者,并且施用量可以由患者的年龄, 体重,性别,健康,饮食,疾病严重程度等。 含有新橙皮苷二氢查耳酮的组合物可以以diosmin的0.01〜20重量%,优选0.1〜5重量%的量添加到食品和饮料中。

    탄닌 또는 탄닌 유래 페놀성 화합물을 포함하는 동맥경화증, 고지혈증 및 간질환의 예방 및 치료용 조성물
    23.
    发明公开
    탄닌 또는 탄닌 유래 페놀성 화합물을 포함하는 동맥경화증, 고지혈증 및 간질환의 예방 및 치료용 조성물 无效
    包含从鞣剂衍生的鞣制或酚醛化合物的组合物,用于预防和治疗高脂血症,肠梗塞和肝病

    公开(公告)号:KR1020000019718A

    公开(公告)日:2000-04-15

    申请号:KR1019980037961

    申请日:1998-09-15

    Abstract: PURPOSE: A pharmaceutical composition and functional food and drink comprising tannin or phenol-type compounds derived from tannin are provided, for treating and preventing hyper lipidemia, arteriosclerosis and a liver disease. CONSTITUTION: The pharmaceutical composition comprises tannin, gallic acid, ellagic acid or their mixture in effective amount; and pharmaceutically acceptable carriers. The functional food or drink comprises 0.01-20 wt%, preferably 0.1-5 wt% of tannin, gallic acid, ellagic acid or their mixture. Tannin, gallic acid and ellagic acid reduce the concentration of serum GOT (glutamate-oxaloacetate transaminase), GPT (glutamate-pyruvate transminase), gamma GTP (gamma-glutamyl transpeptidase) and a lipid in blood, and inhibit the damage of a liver cell and the formation of a fatty liver. Also tannin, gallic acid and ellagic acid strongly inhibit the macrophage-lipid complex from being deposited or adsorbed onto the intra trial surface.

    Abstract translation: 目的:提供包含单宁衍生的单宁或酚型化合物的药物组合物和功能性食品和饮料,用于治疗和预防高脂血症,动脉硬化和肝脏疾病。 构成:药物组合物含有有效量的单宁,没食子酸,鞣花酸或其混合物; 和药学上可接受的载体。 功能性食品或饮料包含0.01-20重量%,优选0.1-5重量%的单宁,没食子酸,鞣花酸或其混合物。 单宁,没食子酸和鞣花酸降低血清GOT(谷氨酸 - 草酰乙酸转氨酶),GPT(谷氨酸 - 丙酮酸转氨酶),γGTP(γ-谷氨酰转肽酶)和血脂中的血清浓度,抑制肝细胞损伤 并形成脂肪肝。 单宁,没食子酸和鞣花酸强烈地抑制巨噬细胞 - 脂质复合物沉积或吸附到试验表面。

    건강증진용 양념 조성물
    24.
    发明授权
    건강증진용 양념 조성물 失效
    用于健康促进的调味组合物

    公开(公告)号:KR100428936B1

    公开(公告)日:2004-04-28

    申请号:KR1019990011996

    申请日:1999-04-07

    Abstract: PURPOSE: A condiment composition containing garlic, onion, ginger, jujubes, powder or extracts of a tangerine pericarp is provided. It has an effect of improving health through prevention of circulatory organ-related diseases when added to food. CONSTITUTION: The condiment composition contains 1 to 30% by weight of garlic, 10 to 50% by weight of onion, 0.2 to 10% by weight of ginger, 5 to 40% by weight of jujubes, tangerines, powder or extract of a tangerine pericarp and additionally 30 to 50% by weight of oatmeal powder, based on the total weight of the composition. The tangerine pericarp extract is prepared by adding 3 to 30L 20 to 95% ethanol to 1kg tangerine pericarp, extracting for 1 to 12hr at 25 to 80deg.C and then filtering.

    바이오플라보노이드계화합물을포함하는혈청고밀도지단백질증가용조성물

    公开(公告)号:KR100363180B1

    公开(公告)日:2003-01-24

    申请号:KR1019980043909

    申请日:1998-10-20

    Abstract: PURPOSE: A composition for increasing serum high density lipoprotein containing bioflavonoids is provided which is useful for preventing and treating diseases of cardiac circulatory organs. CONSTITUTION: The medical composition for increasing high density lipoprotein consists of(i) an effective amount of bioflavonoids of the following general formula(I) or a plant extract containing thereof, where each R¬1-R¬9 is independently hydrogen, hydroxy, alkoxy having 1-9 carbon atoms(optionally, which is able to include hydroxy, alkoxy having 1-5 carbon atoms, aryloxy or phenyl group which is substituted by one to three substituents selected from hydroxy, alkoxy, aryloxy, halogen, nitro and amido), cycloalkyloxy having 5-9 carbon atoms which is substituted by one to three substituents selected from hydroxy, alkoxy, aryloxy, halogen, nitro and amido, cycloalkylcarbonyloxy having 5-9 carbon atoms which is substituted by one to three substituents selected from hydroxy, alkoxy, aryloxy, halogen, nitro and amido, acyloxy having 2-10 or 16-18 carbon atoms(optionally, which is able to include hydroxy, alkoxy having 1-5 carbon atoms, aryloxy or phenyl group which is substituted by one to three substituents selected from hydroxy, alkoxy, aryloxy, halogen, nitro and amido), or rutinosyl, and X is either a single bond or a double bond; and (ii) a medically acceptable carrier.

    Abstract translation: 目的:提供一种用于增加含血清高密度脂蛋白的生物类黄酮的组合物,其用于预防和治疗心脏循环器官疾病。 组成:用于增加高密度脂蛋白的药物组合物由(i)有效量的下列通式(I)的生物类黄酮或含有其的植物提取物组成,其中每个R 1 -R 1不是9独立地是氢,羟基, 具有1-9个碳原子的烷氧基(任选地,其能够包括羟基,具有1-5个碳原子的烷氧基,芳氧基或被1-3个选自羟基,烷氧基,芳氧基,卤素,硝基和酰氨基 ),被一至三个选自羟基,烷氧基,芳氧基,卤素,硝基和酰氨基的取代基取代的具有5-9个碳原子的环烷氧基,具有5-9个碳原子的环烷氧基,其被1-3个选自羟基, 烷氧基,芳氧基,卤素,硝基和酰氨基,具有2-10或16-18个碳原子的酰氧基(任选地,其可以包括羟基,具有1-5个碳原子的烷氧基,芳氧基或被取代的苯基 y选自羟基,烷氧基,芳氧基,卤素,硝基和酰氨基的1至3个取代基)或芸香糖基,X为单键或双键; 和(ii)医学上可接受的载体。

    감귤류과피추출액을포함하는아실코에이:콜레스테롤-오르토-아실트랜스퍼레이즈저해제조성물
    30.
    发明授权
    감귤류과피추출액을포함하는아실코에이:콜레스테롤-오르토-아실트랜스퍼레이즈저해제조성물 失效
    ACYL COA:包含CITRUS PEEL提取物的胆固醇-O-亚氨基转移酶抑制剂组合物

    公开(公告)号:KR100258584B1

    公开(公告)日:2000-07-01

    申请号:KR1019970055580

    申请日:1997-10-28

    Abstract: PURPOSE: A composition containing orange peel extract for inhibition of acyl CoA:cholesterol-O-acyltransferase(ACAT) is provided, which is useful for preventing and treating various cardiovascular diseases by decreasing blood low density lipoprotein(LDL) cholesterol. CONSTITUTION: A process fro the preparation of composition containing orange peel extract for inhibition of acyl CoA:cholesterol-O-acyltransferase(ACAT) comprises the steps of: washing the peel of tangerine originated in Korea, and drying at normal temperature to get Aurantii Nobilis Pericarpium; adding 95% ethanol, keeping at normal temperature for 24hours, and filtering to get extract and solid residue; extracting the solid residue twice more by the same process, and gathering extracts altogether; and concentrating the extract using a rotary vacuum evaporator under decompression to get concentrated extract containing bio-flavonoids.

    Abstract translation: 目的:提供含有抑制酰基CoA:胆固醇-O-酰基转移酶(ACAT)的橙皮提取物的组合物,其可用于通过降低血液低密度脂蛋白(LDL)胆固醇来预防和治疗各种心血管疾病。 构成:含有橙皮提取物抑制酰基CoA:胆固醇-O-酰基转移酶(ACAT)的组合物的制备方法包括以下步骤:洗涤起始于韩国的橘皮,并在常温下干燥以得到Aurantii Nobilis Pericarpium; 加入95%乙醇,在常温保持24小时,过滤得到提取物和固体残渣; 通过相同的方法提取固体残渣两次,并收集提取物; 并在减压下使用旋转式真空蒸发器浓缩提取物,得到含有生物黄酮的浓缩提取物。

Patent Agency Ranking